Reducing Lung Cancer Survivors' Anxiety and Dyspnea (RELAX)
Overview
Overview
The purpose of this research study is to compare the effects of music and different levels of device-guided breathing on anxiety and shortness of breath in lung cancer survivors.
Key Inclusion Criteria
Key Inclusion Criteria
For a patient to be eligible for participation in this study, all of the following criteria must apply.
- Histologic or cytologic diagnosis of primary non-small cell Stage 0-II lung cancer,
- 2- 24 months post-completion of surgery, radiation therapy and/or chemotherapy with no further planned treatment during the 8-week study
- Score of ≥8 on the anxiety subscale of the HADS1
- Eastern Cooperative Oncology Group performance status 0-2
- Hemoglobin ≥9.5
- Smoking status anticipated to be stable during the study
- Willing/able to attend brief introductory session and use assigned device for the assigned period of time (15 minutes once or twice per day), 5 days per week for 8 weeks.
- Age ≥18 years
Key Exclusion Criteria
Key Exclusion Criteria
A patient will not be eligible for participation in this study if any of the following criteria apply.
- Patient does not understand English
- Active lung infection
- Radiation pneumonitis currently being treated with oral steroids
- Unstable angina
- Pulmonary embolism in past six months
- Progressive cancer (must be considered no evidence of disease or stable)
- Active suicidal ideation with plan or intent
- Any change in psychotropic medications in past month
- Hearing loss that would preclude participating in interventions.
Learn More
Learn More
To learn more, visit ClinicalTrials.Gov
Study Type
Phase: N/A
Principal Investigator(s)
Patricia Griffin, MD
Sponsor(s)
Wake Forest University Health Sciences
Contact Us
Contact Us
For more information about this study, please contact Clinical Research at
864-560-6812